Related references
Note: Only part of the references are listed.MRI-informed muscle biopsies correlate MRI with pathology and DUX4 target gene expression in FSHD
Leo H. Wang et al.
HUMAN MOLECULAR GENETICS (2019)
The DUX4 homeodomains mediate inhibition of myogenesis and are functionally exchangeable with the Pax7 homeodomain
Darko Bosnakovski et al.
JOURNAL OF CELL SCIENCE (2017)
Conserved roles of mouse DUX and human DUX4 in activating cleavage-stage genes and MERVL/HERVL retrotransposons
Peter G. Hendrickson et al.
NATURE GENETICS (2017)
Conservation and innovation in the DUX4-family gene network
Jennifer L. Whiddon et al.
NATURE GENETICS (2017)
PAX7 target genes are globally repressed in facioscapulohumeral muscular dystrophy skeletal muscle
Christopher R. S. Banerji et al.
NATURE COMMUNICATIONS (2017)
BET bromodomain inhibitors and agonists of the beta-2 adrenergic receptor identified in screens for compounds that inhibit DUX4 expression in FSHD muscle cells
Amy E. Campbell et al.
SKELETAL MUSCLE (2017)
Mutations in DNMT3B Modify Epigenetic Repression of the D4Z4 Repeat and the Penetrance of Facioscapulohumeral Dystrophy
Marlinde L. van den Boogaard et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2016)
DUX4 induces a transcriptome more characteristic of a less-differentiated cell state and inhibits myogenesis
Paul Knopp et al.
JOURNAL OF CELL SCIENCE (2016)
DUX4 recruits p300/CBP through its C-terminus and induces global H3K27 acetylation changes
Si Ho Choi et al.
NUCLEIC ACIDS RESEARCH (2016)
Effects of vitamin C, vitamin E, zinc gluconate, and selenomethionine supplementation on muscle function and oxidative stress biomarkers in patients with facioscapulohumeral dystrophy: A double-blind randomized controlled clinical trial
Emilie Passerieux et al.
FREE RADICAL BIOLOGY AND MEDICINE (2015)
β-catenin is central to DUX4-driven network rewiring in facioscapulohumeral muscular dystrophy
Christopher R. S. Banerji et al.
JOURNAL OF THE ROYAL SOCIETY INTERFACE (2015)
DUX4-induced gene expression is the major molecular signature in FSHD skeletal muscle
Zizhen Yao et al.
HUMAN MOLECULAR GENETICS (2014)
Population-based incidence and prevalence of facioscapulohumeral dystrophy
Johanna C. W. Deenen et al.
NEUROLOGY (2014)
High-throughput screening identifies inhibitors of DUX4-induced myoblast toxicity
Darko Bosnakovski et al.
SKELETAL MUSCLE (2014)
Facioscapulohumeral dystrophy: the path to consensus on pathophysiology
Rabi Tawil et al.
SKELETAL MUSCLE (2014)
Clinical and genetic features of hearing loss in facioscapulohumeral muscular dystrophy
Katie L. Lutz et al.
NEUROLOGY (2013)
NCBI GEO: archive for functional genomics data sets-update
Tanya Barrett et al.
NUCLEIC ACIDS RESEARCH (2013)
DUX4 Activates Germ line Genes, Retroelements, and Immune Mediators: Implications for Facioscapulohumeral Dystrophy
Linda N. Geng et al.
DEVELOPMENTAL CELL (2012)
Functional muscle impairment in facioscapulohumeral muscular dystrophy is correlated with oxidative stress and mitochondrial dysfunction
Ahmed Turki et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Facioscapulohumeral muscular dystrophy (FSHD): an enigma unravelled?
Mark Richards et al.
HUMAN GENETICS (2012)
Facioscapulohumeral muscular dystrophy family studies of DUX4 expression: evidence for disease modifiers and a quantitative model of pathogenesis
Takako Iida Jones et al.
HUMAN MOLECULAR GENETICS (2012)
Digenic inheritance of an SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2
Richard J. L. F. Lemmers et al.
NATURE GENETICS (2012)
Mutation spectrum and phenotypic manifestation in FSHD Greek patients
P. Sakellariou et al.
NEUROMUSCULAR DISORDERS (2012)
FSHD Myotubes with Different Phenotypes Exhibit Distinct Proteomes
Alexandra Tassin et al.
PLOS ONE (2012)
Transcriptional profiling in facioscapulohumeral muscular dystrophy to identify candidate biomarkers
Fedik Rahimov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
pROC: an open-source package for R and S plus to analyze and compare ROC curves
Xavier Robin et al.
BMC BIOINFORMATICS (2011)
Retinal vascular disease and the pathogenesis of facioscapulohumeral muscular dystrophy. A signalling message from Wnt?
Robin B. Fitzsimons
NEUROMUSCULAR DISORDERS (2011)
Myoblasts from affected and non-affected FSHD muscles exhibit morphological differentiation defects
Marietta Barro et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2010)
A Unifying Genetic Model for Facioscapulohumeral Muscular Dystrophy
Richard J. L. F. Lemmers et al.
SCIENCE (2010)
Facioscapulohumeral Dystrophy: Incomplete Suppression of a Retrotransposed Gene
Lauren Snider et al.
PLOS GENETICS (2010)
Specific Loss of Histone H3 Lysine 9 Trimethylation and HP1 gamma/Cohesin Binding at D4Z4 Repeats Is Associated with Facioscapulohumeral Dystrophy (FSHD)
Weihua Zeng et al.
PLOS GENETICS (2009)
An isogenetic myoblast expression screen identifies DUX4-mediated FSHD-associated molecular pathologies
Darko Bosnakovski et al.
EMBO JOURNAL (2008)
DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1
Manjusha Dixit et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
The DUX4 gene at the FSHDIA locus encodes a pro-apoptotic protein
Valeria Kowaljow et al.
NEUROMUSCULAR DISORDERS (2007)
Asymptomatic carriers and gender differences in facioscapulohumeral muscular dystrophy (FSHD)
MMO Tonini et al.
NEUROMUSCULAR DISORDERS (2004)
Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation
ST Winokur et al.
HUMAN MOLECULAR GENETICS (2003)
Share Paper
